Karon

Alprostadil, the active ingredient in Karon, is a prostaglandin analog presented as an unspecified strength/solution for intracavernous use. It treats erectile dysfunction in adult men by facilitating penile erection. GNH USA supplies Karon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Alprostadil is used in the management of erectile dysfunction, a condition affecting penile blood flow.

Erectile dysfunction: improves the ability to achieve and maintain an erection sufficient for sexual activity.

Alprostadil may cause a range of adverse reactions, which are generally categorized by frequency.

Common Side Effects: - Penile pain - Priapism (prolonged erection) - Erythema or swelling at the injection site - Bleeding or hematoma at the injection site - Headache - Flushing

Serious or Rare Side Effects: - Severe priapism lasting more than four hours - Systemic hypotension - Allergic reaction, including rash or anaphylaxis - Infection at the injection site

When prescribing Alprostadil, clinicians should consider several safety aspects.

Contraindicated in patients with known hypersensitivity to alprostadil or prostaglandins: avoid use. Avoid in men with severe penile anatomical abnormalities (e.g., curvature, fibrosis): risk of injury. Use caution in patients with cardiovascular disease: monitor for hypotension. Do not combine with other vasodilators without medical supervision: increased risk of priapism. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Alprostadil can interact with other agents that affect vascular tone or coagulation.

Major Interactions (Avoid): - Concomitant use of phosphodiesterase‑5 inhibitors (e.g., sildenafil) – may cause excessive vasodilation and priapism. - Systemic vasodilators (e.g., nitroglycerin) – risk of severe hypotension. - Anticoagulants (e.g., warfarin) – increased bleeding at injection site.

Moderate Interactions (Monitor Closely): - Alpha‑blockers – may enhance blood‑pressure‑lowering effect. - Other prostaglandin analogs – additive vasodilatory effect. - Drugs affecting platelet function (e.g., aspirin) – monitor for bleeding.